C12P 21/06
Produced by the hydrolysis of a peptide bond
Official title: produced by the hydrolysis of a peptide bond, e.g. hydrolysate products (preparing foodstuffs by protein hydrolysis A23J3/00)
C12P21/06 (Produced by the hydrolysis of a peptide bond) appears on 761 US grants and 1,420 published applications in this corpus.
Search patents in C12P- Granted patents
- 761
- Published applications
- 1,420
- Assignees
- 559
- Inventors
- 2,389
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 1 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 2 | 0 |
| 1986 | 1 | 0 |
| 1987 | 4 | 0 |
| 1988 | 2 | 0 |
| 1989 | 0 | 0 |
| 1990 | 4 | 0 |
| 1991 | 3 | 0 |
| 1992 | 6 | 0 |
| 1993 | 7 | 0 |
| 1994 | 9 | 0 |
| 1995 | 5 | 0 |
| 1996 | 13 | 0 |
| 1997 | 14 | 0 |
| 1998 | 14 | 0 |
| 1999 | 19 | 0 |
| 2000 | 14 | 0 |
| 2001 | 10 | 3 |
| 2002 | 10 | 16 |
| 2003 | 7 | 444 |
| 2004 | 7 | 43 |
| 2005 | 7 | 39 |
| 2006 | 25 | 36 |
| 2007 | 81 | 41 |
| 2008 | 82 | 25 |
| 2009 | 24 | 39 |
| 2010 | 20 | 29 |
| 2011 | 16 | 45 |
| 2012 | 13 | 51 |
| 2013 | 30 | 42 |
| 2014 | 23 | 45 |
| 2015 | 16 | 49 |
| 2016 | 28 | 41 |
| 2017 | 33 | 35 |
| 2018 | 23 | 42 |
| 2019 | 20 | 38 |
| 2020 | 20 | 32 |
| 2021 | 26 | 49 |
| 2022 | 31 | 57 |
| 2023 | 18 | 47 |
| 2024 | 35 | 49 |
| 2025 | 26 | 47 |
| 2026 | 11 | 36 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Collagenase agent and use thereof29 Sep 2026US 12,747,435 B2Amano Enzyme Inc.
- Gryllus bimaculatus extract and method for preparing the same15 Sep 2026US 12,733,659 B2Cj Cheiljedang Corporation
- Lipase variants and polynucleotides encoding same4 Aug 2026US 12,698,488 B2Novozymes A/S
- Extracellular matrix-derived gels and related methods16 Jun 2026US 12,653,926 B2University of Pittsburgh—Of the Commonwealth System of Higher Education
- Hydrolyzed collagen for use in reducing blood glucose26 May 2026US 12,636,339 B2Rousselot B.V.
- Anti-vegf protein compositions and methods for producing the same8 Oct 2026US 2026/0308231 A1Regeneron Pharmaceuticals, Inc.
- Anti-vegf protein compositions and methods for producing the same8 Oct 2026US 2026/0308232 A1Regeneron Pharmaceuticals, Inc.
- Anti-vegf protein compositions and methods for producing the same8 Oct 2026US 2026/0308233 A1Regeneron Pharmaceuticals, Inc.
- Lipase Variants and Polynucleotides Encoding Same8 Oct 2026US 2026/0308548 A1Novozymes A/S
- Peptides prepared from a plant extract obtained by protease digestion1 Oct 2026US 2026/0297644 A1Valogen Biosciences Limited
Most cited
By later US patents
- Proteolysis targeting chimeric pharmaceutical167US 7,041,298 B2California Institute of Technology · 2006
- Metabolically activated recombinant viral vectors and methods for the preparation and use163US 6,596,535 B1Targeted Genetics Corporation · 2003
- Proteolysis targeting chimeric pharmaceutical161US 7,208,157 B2California Institute of Technology · 2007
- Metabolically activated recombinant viral vectors and methods for their preparation and use142US 7,125,717 B2Targeted Genetics Corporation · 2006
- Oligonucleotide mediated nucleic acid recombination137US 8,058,001 B2Codexis Mayflower Holdings, LLC · 2011